Impact of Institutional - and Individual - Level Discrimination on Medical Care & Quality of Life Among Breast Cancer Survivors

Abstract

During this reporting period, we completed qualitative one-on-one and focus group interviews with breast cancer survivors from 7 racial/ethnic groups (see Appendix A), continued rigorous analysis of the qualitative data, systematizing the data such that specific themes were identified, conducted an exhaustive assessment of existing literature and instruments for survey development, combined results of the qualitative analysis and literature review, and successfully developed a comprehensive quantitative survey for cognitive testing. This instrument incorporates relevant items from existing tools as well as de-novo questions aimed to address novel themes identified in the qualitative data. We reviewed each survey question for potential problems and developed specific cognitive questions to test for these problems accordingly. We conducted extensive training on the cognitive instrument and are in the process of translating the survey and cognitive instrument into Spanish, Chinese and Tagalog. We have completed 2 initial drafts of manuscripts to report the qualitative findings and we have plans for a third manuscript based on the instrument development process.

Open PDF

Document Details

Document Type
Technical Report
Publication Date
Jul 01, 2010
Accession Number
ADA542282

Entities

People

  • Scarlett L. Gomez

Organizations

  • Cancer Prevention Institute of California

Tags

DTIC Thesaurus Topics

  • Biomedical Research
  • Breast Cancer
  • California
  • Communities
  • Data Analysis
  • Department Of Defense
  • Discrimination
  • Ethnic Groups
  • Geographic Information Systems
  • Geographic Regions
  • Health
  • Health Care
  • Information Systems
  • Literature
  • Minority Groups
  • Neoplasms
  • Quality Of Life

Readers

  • Organizational Process Management (OPM).
  • Systems Analysis and Design
  • Traumatic Brain Injury (TBI) and Cognitive Aging in the Guam and Border Populations Affected by Alzheimer's Disease and Tau-Associated Dementias.